update on finding of Ataluren FDA approval

[Srobison]

<table style="width: 619px;" border="0" cellspacing="0" cellpadding="0" align="left">
<tbody>
<tr>
<td class="pagename" style="background-color: #cfcfcf; height: 36px;" align="left" bgcolor="#cfcfcf">
<div style="margin-left: 10px; padding-top: 6px;">TODAY ON PHARMALIVE.COM
</td>
</tr>
</tbody>
</table>
<div id="dhtmltooltip">

<div style="margin-top: 12px; display: block; clear: both; padding-top: 5px;">
<div class="headerNC">Top-line Data From Phase 3 Trial of Ataluren in Patients with Nonsense Mutation Cystic Fibrosis Show Promising Results

<div class="like-share">

 

[Srobison]

<a href="http://www.pharmalive.com/news/index.cfm?articleid=843785">http://www.pharmalive.com/news/index.cfm?articleid=843785</a>
FDA approved it for fast track!!!!

 

[Rebjane]

Where is that news release do you see anything about the FDA and it being fast tracked? I do not see that.

 

[Rebjane]

http://www.drugs.com/clinical_trials/top-line-data-phase-3-trial-ataluren-patients-nonsense-mutation-cystic-fibrosis-show-promising-13812.html

Maybe it was at the end of this article?

 

[musclemania70]

"The FDA and the European Commission have granted ataluren Orphan Drug status for the treatment of nonsense mutation cystic fibrosis and nonsense mutation Duchenne and Becker muscular dystrophy. The FDA has also granted ataluren Subpart E designation for expedited development, evaluation, and marketing for CF and dystrophinopathy and Fast Track designation for the development of treatment for nonsense mutation dystrophinopathy"